Cowen & Co.


Analysts Bullish on Omeros Corporation (OMER) Following Positive Additional Data for OMS721

Omeros Corporation (NASDAQ:OMER) shot up more than 60% in pre-market trading on Tuesday after the pharmaceutical company announced additional positive data for OMS721 …

Analysts Remain Bullish Following Glu Mobile Inc. (GLUU) Q2 Earnings

Glu Mobile Inc. (NASDAQ: GLUU), a publisher of mobile games for smartphone and tablet devices, released its Q2 fiscal 2015 earnings on August …

The Top 3 Best Analyst Coverage on Yelp Inc (YELP)

Yelp Inc (NYSE:YELP) is scheduled to announce second-quarter 2015 earnings after market close on Tuesday, July 28. The Street anticipates the company to post $0.

Cowen & Co Weighs in on Biotech Ahead of Earnings: Biogen Inc (BIIB), Celgene Corporation (CELG), Incyte Corporation (INCY)

Cowen and Co.’s Eric Schmidt covers several companies in the biotechnology sector.

Cowen’s Q2 Insights: Gilead Sciences, Inc.(GILD), GW Pharmaceuticals PLC- ADR (GWPH), Ariad Pharmaceuticals, Inc. (ARIA)

Second quarter earnings season is upon us and Cowen & Co. is counting on the biotechnology sector to deliver.

Cowen Initiates Outperform On Cytokinetics, Inc.; Sees 36% Upside For The Stock

In a research report released on Wednesday, Cowen analyst Ritu Baral initiated coverage on shares of Cytokinetics Inc. (NASDAQ:CYTK) with an Outperform rating and …

Analyst Have Mixed Reviews As Intel Corporation (INTC) Falls 19% Year-Over-Year

Broader stock markets are starting to rollover and volatility is on the rise as the market moves into earning season. One stock that …

Cowen Reiterates Outperform on XOMA Corp Ahead of EYEGUARD-B Trial Results

Cowen analyst Phil Nadeau weighed in today with a few insights on XOMA Corp (NASDAQ:XOMA), as data from gevokizumab’s EYEGUARD-B trial is expected over the next couple of weeks. This program …

DRAM Volatility Reflected in Micron Technology, Inc. (MU) Earnings: Analysts Weigh In

Due to disappointing earnings numbers on June 25, shares of Micron Technology, Inc. (NASDAQ:MU) plummeted 18.

Cowen & Co. Initiates Outperform on Heron Therapeutics; Sees 33% Upside For The Stock

Cowen & Co. analyst Boris Peaker initiated coverage on shares of Heron Therapeutics Inc (NASDAQ:HRTX) with an Outperform rating and a price target of …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts